Respiratory Diagnostics - Global Market Outlook (2020 -2028)

   |      |      |  

Respiratory Diagnostics - Global Market Outlook (2020 -2028)

Global Respiratory Diagnostics Market is accounted for $6.94 billion in 2020 and is expected to reach $14.14 billion by 2028 growing at a CAGR of 9.3% during the forecast period. The rising prevalence of respiratory diseases and technological advancements are the major factors propelling market growth. However, reimbursement concerns are hampering market growth.

Respiratory diagnostics have a principal part in the therapeutic innovation area. It involves the clinical assessment of some kinds of respiratory conditions such as bronchitis, asthma, COPD, pulmonary fibrosis among others by using various kinds of mechanical, imaging, and molecular diagnostics tests.

Based on the test type, the traditional diagnostic tests segment is estimated to have a lucrative growth due to it is widely used by developing countries and the fast working time of these tests allows patients to get effective results in a shorter period which further improves treatment procedures.

By geography, North America is going to have a lucrative growth during the forecast period due to the increasing prevalence of respiratory diseases and the growing anti-aging population. The U.S. dominates North America's respiratory diagnostics market due to its advanced healthcare system and strong distribution channels.

Some of the key players profiled in the Respiratory Diagnostics Market include Abbott Diagnostics Inc., Becton, Dickinson and Company, CAREstream Medical Ltd., Fisher & Paykel Healthcare, Inc., GE Healthcare Limited, Koninklijke Philips N.V, Medtronic, Inc., MGC Diagnostics Corporation, ResMed Inc., Thermo Fisher Scientific Inc., 3M, Philips Healthcare, Biomérieux, COSMED, Bio-Rad Laboratories Inc., SDI Diagnostics, Seegene Inc., and Alere Inc.
 
Test Types Covered:
• Imaging Tests
• Mechanical Tests
• Molecular Diagnostic Tests
• Traditional Diagnostic Tests

Product and Services Covered:
• Assays and Kits/Reagents
• Instruments and Devices
• Services and Software

Diseases Covered:
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Cancer
• Tuberculosis
• Other Diseases

Distribution Channels Covered:
• Retail Sales
• Direct Tender

End Users Covered:
• Hospital/Clinical Laboratories
• Physician Offices
• Reference Laboratories
• Clinics
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

 

1 Executive Summary          
           
2 Preface          
 2.1 Abstract         
 2.2 Stake Holders         
 2.3 Research Scope         
 2.4 Research Methodology         
  2.4.1 Data Mining        
  2.4.2 Data Analysis        
  2.4.3 Data Validation        
  2.4.4 Research Approach        
 2.5 Research Sources         
  2.5.1 Primary Research Sources        
  2.5.2 Secondary Research Sources        
  2.5.3 Assumptions        
           
3 Market Trend Analysis          
 3.1 Introduction         
 3.2 Drivers         
 3.3 Restraints         
 3.4 Opportunities         
 3.5 Threats         
 3.6 Product Analysis          
 3.7 End User Analysis         
 3.8 Emerging Markets         
 3.9 Impact of Covid-19         
           
4 Porters Five Force Analysis          
 4.1 Bargaining power of suppliers         
 4.2 Bargaining power of buyers         
 4.3 Threat of substitutes         
 4.4 Threat of new entrants         
 4.5 Competitive rivalry         
           
5 Global Respiratory Diagnostics Market, By Test Type          
 5.1 Introduction         
 5.2 Imaging Tests         
  5.2.1 Computed Tomography        
  5.2.2 Magnetic Resonance Imaging (MRI)        
  5.2.3 Positron Emission Tomography (PET)        
  5.2.4 X-Ray        
 5.3 Mechanical Tests         
  5.3.1 Pulmonary Function Tests        
   5.3.1.1 Spirometry       
   5.3.1.2 Diffusion Capacity Test       
   5.3.1.3 Plethysmography Test       
  5.3.2 Peak Flow Test        
  5.3.3 Obstructive Sleep Apnoea (OSA) Diagnostic Tests        
   5.3.3.1 Polysomnography       
   5.3.3.2 Home Sleep Apnea Testing       
 5.4 Molecular Diagnostic Tests         
  5.4.1 Nucleic Acid Amplification Test        
  5.4.2 In Situ Hybridization        
  5.4.3 DNA Sequencing & Next-Generation Sequencing (NGS)        
  5.4.4 Microarrays        
  5.4.5 Polymerase Chain Reaction (PCR)        
 5.5 Traditional Diagnostic Tests         
  5.5.1 Biochemical Characterization        
  5.5.2 Microscopy        
  5.5.3 Immunodiagnostics        
           
6 Global Respiratory Diagnostics Market, By Product and Service          
 6.1 Introduction         
 6.2 Assays and Kits/Reagents         
 6.3 Instruments and Devices         
  6.3.1 Tabletop        
  6.3.2 Standalone        
  6.3.3 Portable        
 6.4 Services and Software         
           
7 Global Respiratory Diagnostics Market, By Disease          
 7.1 Introduction         
 7.2 Asthma         
 7.3 Chronic Obstructive Pulmonary Disease (COPD)         
 7.4 Lung Cancer         
 7.5 Tuberculosis         
 7.6 Other Diseases         
  7.6.1 Bronchitis         
  7.6.2 Pulmonary Fibrosis        
  7.6.3 Respiratory Infection        
           
8 Global Respiratory Diagnostics Market, By Distribution Channel          
 8.1 Introduction         
 8.2 Retail Sales         
 8.3 Direct Tender         
           
9 Global Respiratory Diagnostics Market, By End User          
 9.1 Introduction         
 9.2 Hospital/Clinical Laboratories         
 9.3 Physician Offices         
 9.4 Reference Laboratories         
 9.5 Clinics         
 9.6 Other End Users         
  9.6.1 Blood Banks        
  9.6.2 Point-Of-Care Testing        
  9.6.3 Patient Self-Testing        
           
10 Global Respiratory Diagnostics Market, By Geography          
 10.1 Introduction         
 10.2 North America          
  10.2.1 US        
  10.2.2 Canada        
  10.2.3 Mexico        
 10.3 Europe         
  10.3.1 Germany        
  10.3.2 UK        
  10.3.3 Italy        
  10.3.4 France        
  10.3.5 Spain        
  10.3.6 Rest of Europe        
 10.4 Asia Pacific         
  10.4.1 Japan        
  10.4.2 China        
  10.4.3 India        
  10.4.4 Australia        
  10.4.5 New Zealand        
  10.4.6 South Korea        
  10.4.7 Rest of Asia Pacific        
 10.5 South America          
  10.5.1 Argentina        
  10.5.2 Brazil        
  10.5.3 Chile        
  10.5.4 Rest of South America        
 10.6 Middle East & Africa         
  10.6.1 Saudi Arabia        
  10.6.2 UAE        
  10.6.3 Qatar        
  10.6.4 South Africa         
  10.6.5 Rest of Middle East & Africa        
           
11 Key Developments          
 11.1 Agreements, Partnerships, Collaborations and Joint Ventures         
 11.2 Acquisitions & Mergers         
 11.3 New Product Launch         
 11.4 Expansions         
 11.5 Other Key Strategies         
           
12 Company Profiling          
 12.1 Abbott Diagnostics Inc.         
 12.2 Becton, Dickinson and Company         
 12.3 CAREstream Medical Ltd.         
 12.4 Fisher & Paykel Healthcare, Inc.         
 12.5 GE Healthcare Limited         
 12.6 Koninklijke Philips N.V         
 12.7 Medtronic, Inc.         
 12.8 MGC Diagnostics Corporation         
 12.9 ResMed Inc.         
 12.10 Thermo Fisher Scientific Inc.         
 12.11 3M         
 12.12 Philips Healthcare         
 12.13 Biomérieux         
 12.14 COSMED         
 12.15 Bio-Rad Laboratories Inc.         
 12.16 SDI Diagnostics         
 12.17 Seegene Inc.         
 12.18 Alere Inc.         

 

Respiratory Diagnostics - Global Market Outlook (2020 -2028)

List of Tables           
1 Global Respiratory Diagnostics Market Outlook, By Region (2019-2028) ($MN)          
2 Global Respiratory Diagnostics Market Outlook, By Test Type (2019-2028) ($MN)          
3 Global Respiratory Diagnostics Market Outlook, By Imaging Tests (2019-2028) ($MN)          
4 Global Respiratory Diagnostics Market Outlook, By Computed Tomography (2019-2028) ($MN)          
5 Global Respiratory Diagnostics Market Outlook, By Magnetic Resonance Imaging (MRI) (2019-2028) ($MN)          
6 Global Respiratory Diagnostics Market Outlook, By Positron Emission Tomography (PET) (2019-2028) ($MN)          
7 Global Respiratory Diagnostics Market Outlook, By X-Ray (2019-2028) ($MN)          
8 Global Respiratory Diagnostics Market Outlook, By Mechanical Tests (2019-2028) ($MN)          
9 Global Respiratory Diagnostics Market Outlook, By Pulmonary Function Tests (2019-2028) ($MN)          
10 Global Respiratory Diagnostics Market Outlook, By Peak Flow Test (2019-2028) ($MN)          
11 Global Respiratory Diagnostics Market Outlook, By Obstructive Sleep Apnoea (OSA) Diagnostic Tests (2019-2028) ($MN)          
12 Global Respiratory Diagnostics Market Outlook, By Molecular Diagnostic Tests (2019-2028) ($MN)          
13 Global Respiratory Diagnostics Market Outlook, By Nucleic Acid Amplification Test (2019-2028) ($MN)          
14 Global Respiratory Diagnostics Market Outlook, By In Situ Hybridization (2019-2028) ($MN)          
15 Global Respiratory Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2019-2028) ($MN)          
16 Global Respiratory Diagnostics Market Outlook, By Microarrays (2019-2028) ($MN)          
17 Global Respiratory Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2019-2028) ($MN)          
18 Global Respiratory Diagnostics Market Outlook, By Traditional Diagnostic Tests (2019-2028) ($MN)          
19 Global Respiratory Diagnostics Market Outlook, By Biochemical Characterization (2019-2028) ($MN)          
20 Global Respiratory Diagnostics Market Outlook, By Microscopy (2019-2028) ($MN)          
21 Global Respiratory Diagnostics Market Outlook, By Immunodiagnostics (2019-2028) ($MN)          
22 Global Respiratory Diagnostics Market Outlook, By Product and Service (2019-2028) ($MN)          
23 Global Respiratory Diagnostics Market Outlook, By Assays and Kits/Reagents (2019-2028) ($MN)          
24 Global Respiratory Diagnostics Market Outlook, By Instruments and Devices (2019-2028) ($MN)          
25 Global Respiratory Diagnostics Market Outlook, By Tabletop (2019-2028) ($MN)          
26 Global Respiratory Diagnostics Market Outlook, By Standalone (2019-2028) ($MN)          
27 Global Respiratory Diagnostics Market Outlook, By Portable (2019-2028) ($MN)          
28 Global Respiratory Diagnostics Market Outlook, By Services and Software (2019-2028) ($MN)          
29 Global Respiratory Diagnostics Market Outlook, By Disease (2019-2028) ($MN)          
30 Global Respiratory Diagnostics Market Outlook, By Asthma (2019-2028) ($MN)          
31 Global Respiratory Diagnostics Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2019-2028) ($MN)          
32 Global Respiratory Diagnostics Market Outlook, By Lung Cancer (2019-2028) ($MN)          
33 Global Respiratory Diagnostics Market Outlook, By Tuberculosis (2019-2028) ($MN)          
34 Global Respiratory Diagnostics Market Outlook, By Other Diseases (2019-2028) ($MN)          
35 Global Respiratory Diagnostics Market Outlook, By Bronchitis (2019-2028) ($MN)          
36 Global Respiratory Diagnostics Market Outlook, By Pulmonary Fibrosis (2019-2028) ($MN)          
37 Global Respiratory Diagnostics Market Outlook, By Respiratory Infection (2019-2028) ($MN)          
38 Global Respiratory Diagnostics Market Outlook, By Distribution Channel (2019-2028) ($MN)          
39 Global Respiratory Diagnostics Market Outlook, By Retail Sales (2019-2028) ($MN)          
40 Global Respiratory Diagnostics Market Outlook, By Direct Tender (2019-2028) ($MN)           
41 Global Respiratory Diagnostics Market Outlook, By End User (2019-2028) ($MN)          
42 Global Respiratory Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2019-2028) ($MN)          
43 Global Respiratory Diagnostics Market Outlook, By Physician Offices (2019-2028) ($MN)          
44 Global Respiratory Diagnostics Market Outlook, By Reference Laboratories (2019-2028) ($MN)          
45 Global Respiratory Diagnostics Market Outlook, By Clinics (2019-2028) ($MN)          
46 Global Respiratory Diagnostics Market Outlook, By Other End Users (2019-2028) ($MN)          
47 Global Respiratory Diagnostics Market Outlook, By Blood Banks (2019-2028) ($MN)          
48 Global Respiratory Diagnostics Market Outlook, By Point-Of-Care Testing (2019-2028) ($MN)          
49 Global Respiratory Diagnostics Market Outlook, By Patient Self-Testing (2019-2028) ($MN)          

 

.